Ventricular arterial stiffening: integrating the pathophysiology.
暂无分享,去创建一个
[1] D. Kass,et al. Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction: Implications for Systolic and Diastolic Reserve Limitations , 2003, Circulation.
[2] Michael D. Schneider,et al. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. , 2003, The Journal of clinical investigation.
[3] A. Tedgui,et al. Differential Regulation of Vascular Focal Adhesion Kinase by Steady Stretch and Pulsatility , 2005, Circulation.
[4] D. Kass,et al. Age and gender affect ventricular-vascular coupling during aerobic exercise. , 2004, Journal of the American College of Cardiology.
[5] H. Hod,et al. External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris. , 2003, Journal of the American College of Cardiology.
[6] John M. Tarbell,et al. Interaction between Wall Shear Stress and Circumferential Strain Affects Endothelial Cell Biochemical Production , 2000, Journal of Vascular Research.
[7] C. H. Chen,et al. Verapamil acutely reduces ventricular-vascular stiffening and improves aerobic exercise performance in elderly individuals. , 1999, Journal of the American College of Cardiology.
[8] A P Avolio,et al. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. , 1985, Circulation.
[9] D. Kass,et al. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy , 2005, Nature Medicine.
[10] A. Cerami,et al. An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] D. Kass,et al. Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker , 2001, Circulation.
[12] R. Busse,et al. EDHF: bringing the concepts together. , 2002, Trends in pharmacological sciences.
[13] H. Struijker‐Boudier,et al. Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases , 2003, Circulation.
[14] M E Safar,et al. Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations. , 2001, American journal of hypertension.
[15] M. Zaccolo,et al. cGMP Catabolism by Phosphodiesterase 5A Regulates Cardiac Adrenergic Stimulation by NOS3-Dependent Mechanism , 2004, Circulation research.
[16] A. Dyer,et al. Pulse Pressure Compared With Other Blood Pressure Indexes in the Prediction of 25-Year Cardiovascular and All-Cause Mortality Rates: The Chicago Heart Association Detection Project in Industry Study , 2001, Hypertension.
[17] M. Quiñones,et al. Simvastatin Induces Regression of Cardiac Hypertrophy and Fibrosis and Improves Cardiac Function in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy , 2001, Circulation.
[18] D. Kass,et al. Mechanisms, pathophysiology, and therapy of arterial stiffness. , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[19] R Tominaga,et al. Pulsatile flow enhances endothelium-derived nitric oxide release in the peripheral vasculature. , 2000, American journal of physiology. Heart and circulatory physiology.
[20] Peter P. Liu,et al. Elafin-overexpressing mice have improved cardiac function after myocardial infarction. , 2004, American journal of physiology. Heart and circulatory physiology.
[21] D. Kass,et al. systolic flow augmentation in hearts ejecting into a model of stiff aging vasculature. Influence on myocardial perfusion-demand balance. , 1995, Circulation research.
[22] D. Kass,et al. Pulse pressure-related changes in coronary flow in vivo are modulated by nitric oxide and adenosine. , 1996, Circulation research.
[23] K. Node,et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. , 2001, The Journal of clinical investigation.
[24] A. Dart,et al. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. , 2002, Journal of the American College of Cardiology.
[25] N. Alp,et al. Regulation of Endothelial Nitric Oxide Synthase by Tetrahydrobiopterin in Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[26] W. White,et al. Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension , 2003, Hypertension.
[27] D. Ingram,et al. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] D. Kass,et al. Effect of reduced aortic compliance on cardiac efficiency and contractile function of in situ canine left ventricle. , 1992, Circulation research.
[29] I. Shiojima,et al. Role of Akt Signaling in Vascular Homeostasis and Angiogenesis , 2002, Circulation research.
[30] W. Sessa,et al. Simvastatin upregulates coronary vascular endothelial nitric oxide production in conscious dogs. , 2000, American journal of physiology. Heart and circulatory physiology.
[31] D. Webb,et al. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[32] P. Cahill,et al. Sustained pulsatile flow regulates endothelial nitric oxide synthase and cyclooxygenase expression in co-cultured vascular endothelial and smooth muscle cells. , 1999, Journal of molecular and cellular cardiology.
[33] M. Safar. Pulse pressure, arterial stiffness, and cardiovascular risk. , 2000, Current opinion in cardiology.
[34] C. Vlachopoulos,et al. Effect of sildenafil on arterial stiffness and wave reflection. , 2009, Vascular medicine.
[35] U. Laufs,et al. Impact of HMG CoA reductase inhibition on small GTPases in the heart. , 2002, Cardiovascular research.
[36] D. Hayoz,et al. Nitric oxide synthase expression in endothelial cells exposed to mechanical forces. , 1998, Hypertension.
[37] R. Busse,et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.
[38] Daniel Levy,et al. Systolic Blood Pressure, Diastolic Blood Pressure, and Pulse Pressure as Predictors of Risk for Congestive Heart Failure in the Framingham Heart Study , 2003, Annals of Internal Medicine.
[39] I. Shiojima,et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. , 2000, Nature Medicine.
[40] M. Chen,et al. Endothelial nitric oxide production during in vitro simulation of external limb compression. , 2002, American journal of physiology. Heart and circulatory physiology.
[41] T. Gillebert,et al. Afterload induced changes in myocardial relaxation: a mechanism for diastolic dysfunction. , 1999, Cardiovascular research.
[42] D. Kass,et al. Specificity of synergistic coronary flow enhancement by adenosine and pulsatile perfusion in the dog , 1999, The Journal of physiology.
[43] B. Sumpio,et al. Cyclic strain activates the pro-survival Akt protein kinase in bovine aortic smooth muscle cells. , 2001, Surgery.
[44] R. Ramasamy,et al. Protein Glycation: A Firm Link to Endothelial Cell Dysfunction , 2004, Circulation research.
[45] Karl Swedberg,et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.
[46] L. Rowell,et al. Disparities Between Aortic and Peripheral Pulse Pressures Induced by Upright Exercise and Vasomotor Changes in Man , 1968, Circulation.
[47] D. Kass,et al. Role of Calcium-Sensitive K+ Channels and Nitric Oxide in In Vivo Coronary Vasodilation From Enhanced Perfusion Pulsatility , 2001, Circulation.
[48] G. Mitchell,et al. Arterial stiffness and wave reflection in hypertension: Pathophysiologic and therapeutic implications , 2004, Current hypertension reports.
[49] Hirofumi Tanaka,et al. Aging, Habitual Exercise, and Dynamic Arterial Compliance , 2000, Circulation.
[50] D. Kass,et al. In vitro system to study realistic pulsatile flow and stretch signaling in cultured vascular cells. , 2000, American journal of physiology. Cell physiology.
[51] D. Kass,et al. Adverse influence of systemic vascular stiffening on cardiac dysfunction and adaptation to acute coronary occlusion. , 1996, Circulation.
[52] C H Chen,et al. Coupled systolic-ventricular and vascular stiffening with age: implications for pressure regulation and cardiac reserve in the elderly. , 1998, Journal of the American College of Cardiology.
[53] D. Kass,et al. Frequency- and Afterload-Dependent Cardiac Modulation In Vivo by Troponin I With Constitutively Active Protein Kinase A Phosphorylation Sites , 2004, Circulation research.
[54] M. Safar,et al. Increased Carotid Wall Elastic Modulus and Fibronectin in Aldosterone-Salt–Treated Rats: Effects of Eplerenone , 2002, Circulation.
[55] D. Kass,et al. Hemodynamic effects of unloading the old heart. , 1999, American journal of physiology. Heart and circulatory physiology.
[56] Saptarsi M. Haldar,et al. Wall Stiffness Suppresses Akt/eNOS and Cytoprotection in Pulse-Perfused Endothelium , 2003, Hypertension.
[57] W. Hundley,et al. Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. , 2001, Journal of the American College of Cardiology.
[58] R. Pilz,et al. This Review Is Part of a Thematic Series on Cyclic Gmp–generating Enzymes and Cyclic Gmp–dependent Signaling, Which Includes the following Articles: Regulation of Nitric Oxide–sensitive Guanylyl Cyclase Cyclic Gmp Phosphodiesterases and Regulation of Smooth Muscle Function Structure, Regulation, and , 2022 .